User:Mr. Ibrahem/Nesiritide

Nesiritide, sold under the brand name Natrecor among others, is a medication developed to treat acute decompensated congestive heart failure. Evidence; however, has failed to show benefit. It is given into a vein.

Common side effects include low blood pressure, headache, nausea, and back pain. Other side effects may include allergic reactions, kidney problems, and death. It is a recombinant form of B-type natriuretic peptide, which results in vasodilatation.

Nesiritide was approved for medical use in the United States in 2001. In the United States it costs about 1,100 USD per 1.5 mg vial. Commercial sale; however, has been discontinued as of 2021.